Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.

Pfizer Inc. PFE today announced that its wholly-owned subsidiary, Parker Tennessee Corp., has accepted for purchase all of the shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of King Pharmaceuticals, Inc. KG at a purchase price of $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes. The shares validly tendered and not validly withdrawn represent approximately 92.5% of the outstanding shares of King common stock. Parker Tennessee Corp. will promptly pay for such shares in accordance with the terms of the tender offer.